Showing results (11-20 of 16) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Annals of Surgical Oncology|September 5, 2023
To Dissect or Not to Dissect: Can We Predict the Presence of Four or More Axillary Lymph Node Metastases in Postmenopausal Women with Clinically Node-Negative Breast Cancer?Clara Farley, Roland Bassett, Funda Meric-Bernstam, et al.Journal of Cancer|August 19, 2017
Impact of Statin Use on Outcomes in Triple Negative Breast CancerSimona F Shaitelman, Michael C Stauder, Pamela Allen, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 14, 2024
Evaluation of traditional targeted axillary dissection eligibility criteria for node-positive breast cancer after neoadjuvant chemotherapy in a prospective multicenter registryCatherine Loveland-Jones, John Gaughan, Abigail Caudle, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2020
Phase II Single-Arm Study of Preoperative Letrozole for Estrogen Receptor-Positive Postmenopausal Ductal Carcinoma In Situ: CALGB 40903 (Alliance)E Shelley Hwang, Terry Hyslop, Laura H Hendrix, et al.Journal of the American College of Surgeons|May 30, 2009
A multi-institutional experience of isolated limb infusion: defining response and toxicity in the USGeorgia M Beasley, Abigail Caudle, Rebecca P Petersen, et al.JAMA Oncology|January 18, 2024
Endocrine-Sensitive Disease Rate in Postmenopausal Patients With Estrogen Receptor-Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or Their Combination: A Phase 3 Randomized Clinical TrialCynthia X Ma, Vera J Suman, Souzan Sanati, et al.Pageof 2